Open AccessAbstract CT161: Phase I clinical trials of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumors
Author(s) -
Paul C. McDonald,
Stephen Chia,
Philippe L. Bédard,
Qunicy Chu,
Michael P. A. Lyle,
Lisa Tang,
Madhu Singh,
Zaihui Zhang,
Claudiu T. Supuran,
Daniel J. Renouf,
Shoukat Dedhar
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct161
Subject(s) - tolerability , medicine , response evaluation criteria in solid tumors , nausea , adverse effect , pharmacokinetics , oncology , pharmacology , vomiting , cancer , discontinuation , clinical trial , phases of clinical research